Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014 (2014), Article ID 748964, 14 pages
http://dx.doi.org/10.1155/2014/748964
Research Article

Korean Red Ginseng Saponin Fraction Rich in Ginsenoside-Rb1, Rc and Rb2 Attenuates the Severity of Mouse Collagen-Induced Arthritis

1Laboratory of Veterinary Physiology and Cell Signaling, College of Veterinary Medicine, Kyungpook National University, Daegu 702-701, Republic of Korea
2Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45219, USA
3Research Center, Dongnam Institute of Radiological & Medical Sciences, Busan 619-953, Republic of Korea
4Debre Markos University, Debre Markos, Ethiopia
5Ginseng Corporation Central Research Institute, Daejeon 305-805, Republic of Korea
6Department of Pharmacology, Inha University School of Medicine, Incheon 400-712, Republic of Korea
7Institute of Traditional Medicine & Bioscience, Daejeon University, Daejeon 300-716, Republic of Korea
8Department of Herbology, College of Korean Medicine, Daegu Hanny University, Gyeongsan 712-715, Republic of Korea
9Department of Genetic Engineering, Sungkyunkwan University, Suwon 440-746, Republic of Korea

Received 30 September 2013; Accepted 5 March 2014; Published 16 April 2014

Academic Editor: Nina Ivanovska

Copyright © 2014 Mehari Endale et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Hegen, J. C. Keith Jr., M. Collins, and C. L. Nickerson-Nutter, “Utility of animal models for identification of potential therapeutics for rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 11, pp. 1505–1515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. U. Müller-Ladner, T. Pap, R. E. Gay, M. Neidhart, and S. Gay, “Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis,” Nature Clinical Practice. Rheumatology, vol. 1, no. 2, pp. 102–110, 2005. View at Google Scholar · View at Scopus
  3. I. B. McInnes and G. Schett, “Cytokines in the pathogenesis of rheumatoid arthritis,” Nature Reviews Immunology, vol. 7, no. 6, pp. 429–442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Scrivo, M. di Franco, A. Spadaro, and G. Valesini, “The immunology of rheumatoid arthritis,” Annals of the New York Academy of Sciences, vol. 1108, pp. 312–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Zwerina, S. Hayer, M. Tohidast-Akrad et al., “Single and combined inhibition of TNF, IL-1 and RANKL pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction,” Arthritis & Rheumatism, vol. 50, no. 1, pp. 277–290, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. I. E. Andersson, C. D. Andersson, T. Batsalova et al., “Design of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritis,” PLoS ONE, vol. 6, no. 3, article e17881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. O. Williams, “Collagen-induced arthritis in mice: a major role for tumor necrosis factor-α,” in Target Discovery and Validation Reviews and Protocols, vol. 361 of Methods in Molecular Biology, pp. 265–284, Humana Press, New Jersey, NJ, USA, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. L. Scott and G. H. Kingsley, “Tumor necrosis factor inhibitors for rheumatoid arthritis,” The New England Journal of Medicine, vol. 355, no. 7, pp. 704–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. Smolen and G. Steiner, “Therapeutic strategies for rheumatoid arthritis,” Nature Reviews Drug Discovery, vol. 2, no. 6, pp. 473–488, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Bernatsky, M. Hudson, and S. Suissa, “Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis,” Rheumatology, vol. 46, no. 7, pp. 1157–1160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Khanna, G. Sethi, K. S. Ahn et al., “Natural products as a gold mine for arthritis treatment,” Current Opinion in Pharmacology, vol. 7, no. 3, pp. 344–351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Rasheed, N. Akhtar, and T. M. Haqqi, “Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes,” Arthritis Research & Therapy, vol. 12, no. 5, article R195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ahmed, “Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise,” Arthritis Research & Therapy, vol. 12, no. 2, article 208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. S. Byun, J. K. Song, Y.-R. Kim et al., “Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes,” Rheumatology, vol. 47, no. 3, pp. 301–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Buhrmann, A. Mobasheri, U. Matis, and M. Shakibaei, “Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment,” Arthritis Research & Therapy, vol. 12, no. 4, article R127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Radad, G. Gille, L. Liu, and W.-D. Rausch, “Use of ginseng in medicine with emphasis on neurodegenerative disorders,” Journal of Pharmacological Sciences, vol. 100, no. 3, pp. 175–186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-W. Qi, C.-Z. Wang, and C.-S. Yuan, “Isolation and analysis of ginseng: advances and challenges,” Natural Product Reports, vol. 28, no. 3, pp. 467–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D.-H. Lee, H.-J. Cho, H.-Y. Kang, M. H. Rhee, and H.-J. Park, “Total saponin from Korean red ginseng inhibits thromboxane A2 production associated microsomal enzyme activity in platelets,” Journal of Ginseng Research, vol. 36, no. 1, pp. 40–46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. E.-H. Sohn, S.-A. Jang, C.-H. Lee et al., “Effects of Korean red ginseng extract for the treatment of atopic dermatitis-like skin lesions in mice,” Journal of Ginseng Research, vol. 35, no. 4, pp. 479–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. K. Tan and J. Vanitha, “Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: a review,” Current Medicinal Chemistry, vol. 11, no. 11, pp. 1423–1430, 2004. View at Google Scholar · View at Scopus
  21. D. C. Lee and A. S. Lau, “Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: a mini-review,” Molecules, vol. 16, no. 4, pp. 2802–2816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J.-S. Park, E.-M. Park, D.-H. Kim et al., “Anti-inflammatory mechanism of ginseng saponins in activated microglia,” Journal of Neuroimmunology, vol. 209, no. 1-2, pp. 40–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-H. Baek, O.-N. Bae, and J. H. Park, “Recent methodology in Ginseng analysis,” Journal of Ginseng Research, vol. 36, no. 2, pp. 119–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Chai, Q. Wang, L. Huang, T. Xie, and Y. Fu, “Ginsenoside Rb1 inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human endothelial cells,” Biological & Pharmaceutical Bulletin, vol. 31, no. 11, pp. 2050–2056, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Ye, Q. Yang, X. Kong et al., “Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats,” Neurochemistry International, vol. 58, no. 3, pp. 391–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-S. Keum, S. S. Han, K.-S. Chun et al., “Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 523-524, pp. 75–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Choi, M. Kim, J. Ryu, and C. Choi, “Ginsenosides compound K and Rh2 inhibit tumor necrosis factor-α-induced activation of the NF-κB and JNK pathways in human astroglial cells,” Neuroscience Letters, vol. 421, no. 1, pp. 37–41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-F. Hu, X.-Y. Song, S.-F. Chu et al., “Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice,” Brain Research, vol. 1374, pp. 8–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Du, B. Cheng, X. Zhu, and C. Ling, “Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects,” The Journal of Immunology, vol. 187, no. 2, pp. 942–950, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-S. Jung, D.-H. Kim, and H.-S. Kim, “Ginsenoside Rh1 suppresses inducible nitric oxide synthase gene expression in IFN-γ-stimulated microglia via modulation of JAK/STAT and ERK signaling pathways,” Biochemical and Biophysical Research Communications, vol. 397, no. 2, pp. 323–328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J.-M. Lu, Q. Yao, and C. Chen, “Ginseng compounds: an update on their molecular mechanisms and medical applications,” Current Vascular Pharmacology, vol. 7, no. 3, pp. 293–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Yu, S. H. Kim, Y. Y. Yang et al., “Inhibition of TBK1/IRF-3 and p38/ATF-2 pathways by ginsenoside Rc is linked to amelioration of macrophage-mediated inflammation and collagen type II-induced arthritis,” Submitted to Biochemical Pharmacology.
  33. T. Yayeh, K.-H. Jung, H.-Y. Jeong et al. et al., “Korean red ginseng saponin fraction downregulates proinflammatory mediators in LPS stimulated RAW264.7 cells and protects mice against endotoxic shock,” Journal of Ginseng Research, vol. 36, no. 3, pp. 263–269, 2012. View at Publisher · View at Google Scholar
  34. D. D. Brand, K. A. Latham, and E. F. Rosloniec, “Collagen-induced arthritis,” Nature Protocols, vol. 2, no. 5, pp. 1269–1275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-I. Lee, P.-M. Hyun, S.-H. Kim et al., “Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library,” Arthritis & Rheumatism, vol. 52, no. 1, pp. 345–353, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. Y.-G. Cho, M.-L. Cho, S.-Y. Min, and H.-Y. Kim, “Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis,” Autoimmunity Reviews, vol. 7, no. 1, pp. 65–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. D. Fleming and G. C. Tsokos, “Complement, natural antibodies, autoantibodies and tissue injury,” Autoimmunity Reviews, vol. 5, no. 2, pp. 89–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Walmsley, P. D. Katsikis, E. Abney et al., “Interleukin-10 inhibition of the progression of established collagen-induced arthritis,” Arthritis & Rheumatism, vol. 39, no. 3, pp. 495–503, 1996. View at Google Scholar · View at Scopus
  39. F. M. Brennan and I. B. McInnes, “Evidence that cytokines play a role in rheumatoid arthritis,” The Journal of Clinical Investigation, vol. 118, no. 11, pp. 3537–3545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Schett, J. Zwerina, and G. Firestein, “The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 909–916, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. E. Sweeney, T. B. Kimbler, and G. S. Firestein, “Synoviocyte innate immune responses: II. Pivotal role of IFN regulatory factor 3,” The Journal of Immunology, vol. 184, no. 12, pp. 7162–7168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Hammaker, D. L. Boyle, and G. S. Firestein, “Synoviocyte innate immune responses: tank-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis,” Rheumatology, vol. 51, no. 4, pp. 610–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. L.-W. Qi, C.-Z. Wang, and C.-S. Yuan, “Ginsenosides from American ginseng: chemical and pharmacological diversity,” Phytochemistry, vol. 72, no. 8, pp. 689–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. J.-S. Park, J. A. Shin, J.-S. Jung et al., “Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 341, no. 1, pp. 59–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. H. A. Kim, S. Kim, S. H. Chang, H. J. Hwang, and Y.-N. Choi, “Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice,” International Immunopharmacology, vol. 7, no. 10, pp. 1286–1291, 2007. View at Publisher · View at Google Scholar · View at Scopus